Tag: BioXcel Therapeutics Inc (NASDAQ: BTAI)

Should investors be concerned about BTAI’s high price-to-sales ratio?

BioXcel Therapeutics Inc (BTAI)'s stock is trading at $4.89 at the moment marking a fall of -1.84% from the...

BTAI’s price-to-free cash flow ratio: How it affects investment decisions

Currently, BioXcel Therapeutics Inc's (BTAI) stock is trading at $6.16, marking a gain of 12.32% from last night's close....

Understanding BTAI stock ratios for better investment decisions

Currently, BioXcel Therapeutics Inc's (BTAI) stock is trading at $4.88, marking a gain of 20.67% from last night's close....

Watch this stock’s price performance: BioXcel Therapeutics Inc (NASDAQ:BTAI)

BioXcel Therapeutics Inc (BTAI)'s stock has witnessed a price hike of 21.91% from the previous close with its current...

BTAI’s price-to-sales ratio: Is it a good investment opportunity?

BioXcel Therapeutics Inc (BTAI)'s stock has witnessed a price hike of 16.03% from the previous close with its current...

How analysts predict BioXcel Therapeutics Inc (BTAI) will perform this quarter?

BioXcel Therapeutics Inc (BTAI)'s stock is trading at $2.16 at the moment marking a rise of 6.69% from the...

BTAI’s price-to-cash ratio: How it affects the stock’s valuation.

In the current trading session, BioXcel Therapeutics Inc's (BTAI) stock is trading at the price of $1.97, a gain...
US Post News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.